Display options
Cite
Sun X, Zhang X, Nian JY, et al. Chinese Herbal Medicine as Adjunctive Therapy to Chemotherapy for Breast Cancer: A Systematic Review and Meta-Analysis. Evid Based Complement Alternat Med. 2016;2016:3281968doi: 10.1155/2016/3281968.
Sun, X., Zhang, X., Nian, J. Y., Guo, J., Yin, Y., Zhang, G. L., Yu, M. W., Zhang, Y., Wang, X. M., Yang, G. W., Yang, L., Cheng, P. Y., & Li, J. P. (2016). Chinese Herbal Medicine as Adjunctive Therapy to Chemotherapy for Breast Cancer: A Systematic Review and Meta-Analysis. Evidence-based complementary and alternative medicine : eCAM, 20163281968. https://doi.org/10.1155/2016/3281968
Sun, Xu, et al. "Chinese Herbal Medicine as Adjunctive Therapy to Chemotherapy for Breast Cancer: A Systematic Review and Meta-Analysis." Evidence-based complementary and alternative medicine : eCAM vol. 2016 (2016): 3281968. doi: https://doi.org/10.1155/2016/3281968
Sun X, Zhang X, Nian JY, Guo J, Yin Y, Zhang GL, Yu MW, Zhang Y, Wang XM, Yang GW, Yang L, Cheng PY, Li JP. Chinese Herbal Medicine as Adjunctive Therapy to Chemotherapy for Breast Cancer: A Systematic Review and Meta-Analysis. Evid Based Complement Alternat Med. 2016;2016:3281968. doi: 10.1155/2016/3281968. Epub 2016 Apr 10. PMID: 27190531; PMCID: PMC4842043.
Copy Download .nbib Format: NLM
Share it on

Evid Based Complement Alternat Med. 2016;2016:3281968. doi: 10.1155/2016/3281968. Epub 2016 Apr 10.

Chinese Herbal Medicine as Adjunctive Therapy to Chemotherapy for Breast Cancer: A Systematic Review and Meta-Analysis.

Evidence-based complementary and alternative medicine : eCAM

Xu Sun, Xing Zhang, Jia-Yun Nian, Jiao Guo, Yi Yin, Gan-Lin Zhang, Ming-Wei Yu, Yi Zhang, Xiao-Min Wang, Guo-Wang Yang, Lin Yang, Pei-Yu Cheng, Jin-Ping Li

Affiliations

  1. Department of Oncology, Beijing Hospital of Traditional Chinese Medicine, Capital Medical University, Beijing 100010, China.
  2. Department of Oncology, Beijing Hospital of Traditional Chinese Medicine, Capital Medical University, Beijing 100010, China; Beijing University of Chinese Medicine, Beijing 100029, China.
  3. Department of Oncology, Third Affiliated Hospital of Henan College of Traditional Chinese Medicine, Zhengzhou 450000, China.
  4. Department of Oncology, Beijing Hospital of Traditional Chinese Medicine, Capital Medical University, Beijing 100010, China; Department of Medical Biochemistry and Microbiology, Uppsala University, 75123 Uppsala, Sweden.

PMID: 27190531 PMCID: PMC4842043 DOI: 10.1155/2016/3281968

Abstract

Chinese herbal medicine (CHM) has been increasingly employed during therapy for breast cancer, but its efficacy remains a matter of debate. This systematic review examined randomized controlled trials to provide a critical evaluation of this treatment. The results demonstrated that the combined use of CHM with chemotherapy may improve the immediate tumor response and reduce chemotherapy-associated adverse events. Our findings highlight the poor quality of Chinese studies, and additional well-designed randomized controlled trials addressing the role of CHM are warranted. The lack of molecular-based evidence for CHM and Zheng has resulted in a limited understanding and acceptance of CHM and traditional Chinese medicine in Western countries. We believe that researchers should immediately explore a CHM-based cure, and CHM should be applied to routine care as soon as conclusive data are available.

References

  1. J Altern Complement Med. 2009 Jun;15(6):613-8 - PubMed
  2. Support Care Cancer. 2013 Apr;21(4):1185-92 - PubMed
  3. Lancet. 2000 Aug 12;356(9229):590-1; author reply 593 - PubMed
  4. PLoS One. 2013;8(2):e57604 - PubMed
  5. Zhongguo Zhong Xi Yi Jie He Za Zhi. 2008 Feb;28(2):152-4 - PubMed
  6. Hypertension. 2006 Nov;48(5):838-45 - PubMed
  7. Scand J Prim Health Care. 2005 Mar;23(1):57-62 - PubMed
  8. J Public Health (Oxf). 2004 Jun;26(2):152-7 - PubMed
  9. Forsch Komplementmed. 2006;13 Suppl 2:4-6 - PubMed
  10. J Clin Oncol. 2000 Sep;18(17):3125-34 - PubMed
  11. Zhongguo Zhong Xi Yi Jie He Za Zhi. 2008 Jan;28(1):68-70 - PubMed
  12. Mini Rev Med Chem. 2013 Jan;13(1):101-5 - PubMed
  13. Pflege. 2004 Dec;17(6):385-94 - PubMed
  14. Breast J. 2006 Nov-Dec;12(6):526-30 - PubMed
  15. Complement Ther Med. 2012 Aug;20(4):240-52 - PubMed
  16. Arch Intern Med. 2009 May 11;169(9):858-66 - PubMed
  17. Zhongguo Zhong Yao Za Zhi. 2014 Mar;39(6):1120-3 - PubMed
  18. Altern Ther Health Med. 2005 Jan-Feb;11(1):42-9 - PubMed
  19. J Altern Complement Med. 2007 Jul-Aug;13(6):643-50 - PubMed
  20. Integr Cancer Ther. 2014 Sep;13(5):371-85 - PubMed
  21. Bull World Health Organ. 2000;78(2):252-7 - PubMed
  22. Complement Ther Med. 2000 Jun;8(2):88-96 - PubMed
  23. Pathol Oncol Res. 2003;9(3):166-9 - PubMed
  24. J Exp Clin Cancer Res. 2009 Aug 12;28:112 - PubMed
  25. Complement Ther Med. 2000 Mar;8(1):32-6 - PubMed
  26. CA Cancer J Clin. 2015 Mar;65(2):87-108 - PubMed
  27. BMC Cancer. 2012 Dec 17;12:603 - PubMed
  28. Anticancer Res. 2006 Mar-Apr;26(2B):1519-29 - PubMed
  29. Control Clin Trials. 1996 Feb;17(1):1-12 - PubMed
  30. Can J Public Health. 1997 May-Jun;88(3):154-8 - PubMed
  31. Semin Oncol. 2002 Dec;29(6):563-74 - PubMed
  32. Open Med. 2009;3(3):e123-30 - PubMed
  33. JAMA. 1998 Nov 11;280(18):1585-9 - PubMed
  34. Complement Ther Med. 2013 Jun;21(3):260-71 - PubMed
  35. Nature. 2011 Dec 21;480(7378):S82-3 - PubMed
  36. J Clin Oncol. 2008 Feb 10;26(5):778-85 - PubMed
  37. BMC Complement Altern Med. 2008 Apr 23;8:14 - PubMed
  38. BMJ. 2011 Oct 18;343:d5928 - PubMed
  39. Cancer J. 2008 Mar-Apr;14(2):85-93 - PubMed
  40. Cancer Invest. 2009 Mar;27(3):334-44 - PubMed
  41. Complement Ther Med. 2015 Aug;23(4):626-32 - PubMed
  42. BMC Cancer. 2013 Mar 28;13:164 - PubMed

Publication Types